Annual event is a key component of the education and outreach activities of Northwestern’s Center for Molecular Innovation and Drug Discovery. The symposium featured a keynote address and scientific poster presentations by scientists working on drug discovery projects across a range of disease areas.
The guidelines – released from the American College of Cardiology and the American Heart Association – will help doctors better identify which patients may benefit from lifestyle changes, drug therapy, or both to help prevent future cardiovascular disease-related events.
New national guidelines change the focus from aiming strictly at reducing bad cholesterol to a more personalized approach.
Northwestern Medicine® scientists have successfully tested a nontoxic therapy that suppresses Lupus in blood samples of people with the autoimmune disease. This is a positive step toward one day developing a vaccine-like therapy that could keep Lupus in remission in the human body without the use of toxic drugs.
Scientists at Northwestern are working to develop the healthcare infrastructure in Nigeria, a nation where an estimated 3 million people are living with HIV/AIDS.
A new algorithm developed by an interdisciplinary team at Northwestern can be used with a physical activity app to predict the location of a phone no matter where an individual carries it.
Three architectural firms have submitted designs for a new Biomedical Research Building for Northwestern University Feinberg School of Medicine and the University is now seeking community input on the proposed designs.
A distinguished physician-scientist and international leader in the treatment of inflammatory bowel disease, Stephen B. Hanauer, MD, will join the medical school on January 1, 2014, as the Clifford Joseph Barborka Professor of Medicine and the medical director of the Digestive Disease Center.
The director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University helped usher in an era of international prominence during his nearly quarter-century at the helm.
Study published in the American Journal of Psychiatry by Crystal Clark, MD, assistant professor of psychiatry and behavioral sciences, shows the blood concentration of the commonly used drug lamotrigine decreases in pregnant women.
